nodes	percent_of_prediction	percent_of_DWPC	metapath
Mafenide—Burning sensation—Mitomycin—urinary bladder cancer	0.0589	0.0636	CcSEcCtD
Mafenide—Tachypnoea—Gemcitabine—urinary bladder cancer	0.0506	0.0547	CcSEcCtD
Mafenide—Dapsone—NAT2—urinary bladder cancer	0.0447	0.606	CrCbGaD
Mafenide—Metabolic acidosis—Etoposide—urinary bladder cancer	0.0374	0.0404	CcSEcCtD
Mafenide—Pancytopenia—Mitomycin—urinary bladder cancer	0.0244	0.0263	CcSEcCtD
Mafenide—Blister—Fluorouracil—urinary bladder cancer	0.0236	0.0255	CcSEcCtD
Mafenide—Dapsone—MPO—urinary bladder cancer	0.0211	0.287	CrCbGaD
Mafenide—Erythema—Mitomycin—urinary bladder cancer	0.0179	0.0193	CcSEcCtD
Mafenide—Pain—Carboplatin—urinary bladder cancer	0.0168	0.0181	CcSEcCtD
Mafenide—Pruritus—Valrubicin—urinary bladder cancer	0.015	0.0162	CcSEcCtD
Mafenide—Diarrhoea—Valrubicin—urinary bladder cancer	0.0145	0.0156	CcSEcCtD
Mafenide—Swelling—Fluorouracil—urinary bladder cancer	0.014	0.0151	CcSEcCtD
Mafenide—Rash—Valrubicin—urinary bladder cancer	0.0134	0.0144	CcSEcCtD
Mafenide—Dermatitis—Valrubicin—urinary bladder cancer	0.0133	0.0144	CcSEcCtD
Mafenide—Dermatitis bullous—Gemcitabine—urinary bladder cancer	0.0131	0.0142	CcSEcCtD
Mafenide—Bone marrow depression—Methotrexate—urinary bladder cancer	0.0131	0.0142	CcSEcCtD
Mafenide—Haemolytic anaemia—Cisplatin—urinary bladder cancer	0.013	0.014	CcSEcCtD
Mafenide—Dermatitis bullous—Fluorouracil—urinary bladder cancer	0.0129	0.0139	CcSEcCtD
Mafenide—Burning sensation—Methotrexate—urinary bladder cancer	0.0127	0.0138	CcSEcCtD
Mafenide—Pain—Mitomycin—urinary bladder cancer	0.0125	0.0135	CcSEcCtD
Mafenide—Bone marrow depression—Epirubicin—urinary bladder cancer	0.0123	0.0132	CcSEcCtD
Mafenide—Pancytopenia—Thiotepa—urinary bladder cancer	0.0123	0.0132	CcSEcCtD
Mafenide—Swelling—Etoposide—urinary bladder cancer	0.0122	0.0131	CcSEcCtD
Mafenide—Face oedema—Gemcitabine—urinary bladder cancer	0.0121	0.0131	CcSEcCtD
Mafenide—Hyperventilation—Epirubicin—urinary bladder cancer	0.012	0.013	CcSEcCtD
Mafenide—Burning sensation—Epirubicin—urinary bladder cancer	0.0119	0.0129	CcSEcCtD
Mafenide—Blister—Epirubicin—urinary bladder cancer	0.0115	0.0124	CcSEcCtD
Mafenide—Bone marrow depression—Doxorubicin—urinary bladder cancer	0.0114	0.0123	CcSEcCtD
Mafenide—Face oedema—Cisplatin—urinary bladder cancer	0.0113	0.0122	CcSEcCtD
Mafenide—Hyperventilation—Doxorubicin—urinary bladder cancer	0.0111	0.012	CcSEcCtD
Mafenide—Burning sensation—Doxorubicin—urinary bladder cancer	0.011	0.0119	CcSEcCtD
Mafenide—Blister—Doxorubicin—urinary bladder cancer	0.0106	0.0115	CcSEcCtD
Mafenide—Eosinophilia—Fluorouracil—urinary bladder cancer	0.0106	0.0114	CcSEcCtD
Mafenide—Haemoglobin—Thiotepa—urinary bladder cancer	0.0104	0.0112	CcSEcCtD
Mafenide—Haemorrhage—Thiotepa—urinary bladder cancer	0.0103	0.0112	CcSEcCtD
Mafenide—Pancytopenia—Gemcitabine—urinary bladder cancer	0.0103	0.0111	CcSEcCtD
Mafenide—Pancytopenia—Fluorouracil—urinary bladder cancer	0.0101	0.0109	CcSEcCtD
Mafenide—Diarrhoea—Mitomycin—urinary bladder cancer	0.00998	0.0108	CcSEcCtD
Mafenide—Pancytopenia—Cisplatin—urinary bladder cancer	0.00961	0.0104	CcSEcCtD
Mafenide—Rash—Mitomycin—urinary bladder cancer	0.0092	0.00993	CcSEcCtD
Mafenide—Dermatitis—Mitomycin—urinary bladder cancer	0.00919	0.00992	CcSEcCtD
Mafenide—Erythema—Thiotepa—urinary bladder cancer	0.00899	0.00971	CcSEcCtD
Mafenide—Pancytopenia—Etoposide—urinary bladder cancer	0.0088	0.0095	CcSEcCtD
Mafenide—Haemoglobin—Gemcitabine—urinary bladder cancer	0.00873	0.00943	CcSEcCtD
Mafenide—Haemorrhage—Gemcitabine—urinary bladder cancer	0.00869	0.00938	CcSEcCtD
Mafenide—Haemoglobin—Fluorouracil—urinary bladder cancer	0.00859	0.00927	CcSEcCtD
Mafenide—Haemorrhage—Fluorouracil—urinary bladder cancer	0.00854	0.00922	CcSEcCtD
Mafenide—Dapsone—PTGS2—urinary bladder cancer	0.00792	0.107	CrCbGaD
Mafenide—Erythema—Gemcitabine—urinary bladder cancer	0.00756	0.00817	CcSEcCtD
Mafenide—Erythema—Fluorouracil—urinary bladder cancer	0.00744	0.00803	CcSEcCtD
Mafenide—Erythema—Cisplatin—urinary bladder cancer	0.00705	0.00761	CcSEcCtD
Mafenide—Dermatitis bullous—Epirubicin—urinary bladder cancer	0.00629	0.00679	CcSEcCtD
Mafenide—Pain—Thiotepa—urinary bladder cancer	0.00628	0.00677	CcSEcCtD
Mafenide—Urticaria—Thiotepa—urinary bladder cancer	0.00583	0.00629	CcSEcCtD
Mafenide—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.00582	0.00628	CcSEcCtD
Mafenide—Face oedema—Epirubicin—urinary bladder cancer	0.0058	0.00627	CcSEcCtD
Mafenide—Eosinophilia—Methotrexate—urinary bladder cancer	0.0055	0.00593	CcSEcCtD
Mafenide—Face oedema—Doxorubicin—urinary bladder cancer	0.00537	0.0058	CcSEcCtD
Mafenide—Pain—Gemcitabine—urinary bladder cancer	0.00528	0.0057	CcSEcCtD
Mafenide—Pancytopenia—Methotrexate—urinary bladder cancer	0.00527	0.00569	CcSEcCtD
Mafenide—Pruritus—Thiotepa—urinary bladder cancer	0.00519	0.0056	CcSEcCtD
Mafenide—Pain—Fluorouracil—urinary bladder cancer	0.00519	0.0056	CcSEcCtD
Mafenide—Eosinophilia—Epirubicin—urinary bladder cancer	0.00514	0.00555	CcSEcCtD
Mafenide—Diarrhoea—Thiotepa—urinary bladder cancer	0.00502	0.00542	CcSEcCtD
Mafenide—Pancytopenia—Epirubicin—urinary bladder cancer	0.00493	0.00533	CcSEcCtD
Mafenide—Pain—Cisplatin—urinary bladder cancer	0.00492	0.00531	CcSEcCtD
Mafenide—Urticaria—Fluorouracil—urinary bladder cancer	0.00482	0.00521	CcSEcCtD
Mafenide—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00476	0.00514	CcSEcCtD
Mafenide—Rash—Thiotepa—urinary bladder cancer	0.00463	0.005	CcSEcCtD
Mafenide—Dermatitis—Thiotepa—urinary bladder cancer	0.00462	0.00499	CcSEcCtD
Mafenide—Pancytopenia—Doxorubicin—urinary bladder cancer	0.00457	0.00493	CcSEcCtD
Mafenide—Pain—Etoposide—urinary bladder cancer	0.00451	0.00487	CcSEcCtD
Mafenide—Haemoglobin—Methotrexate—urinary bladder cancer	0.00447	0.00482	CcSEcCtD
Mafenide—Haemorrhage—Methotrexate—urinary bladder cancer	0.00444	0.0048	CcSEcCtD
Mafenide—Pruritus—Gemcitabine—urinary bladder cancer	0.00437	0.00471	CcSEcCtD
Mafenide—Pruritus—Fluorouracil—urinary bladder cancer	0.00429	0.00464	CcSEcCtD
Mafenide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00422	0.00456	CcSEcCtD
Mafenide—Urticaria—Etoposide—urinary bladder cancer	0.00419	0.00452	CcSEcCtD
Mafenide—Haemoglobin—Epirubicin—urinary bladder cancer	0.00418	0.00451	CcSEcCtD
Mafenide—Haemorrhage—Epirubicin—urinary bladder cancer	0.00416	0.00449	CcSEcCtD
Mafenide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00415	0.00448	CcSEcCtD
Mafenide—Diarrhoea—Cisplatin—urinary bladder cancer	0.00394	0.00425	CcSEcCtD
Mafenide—Rash—Gemcitabine—urinary bladder cancer	0.00389	0.0042	CcSEcCtD
Mafenide—Dermatitis—Gemcitabine—urinary bladder cancer	0.00389	0.0042	CcSEcCtD
Mafenide—Erythema—Methotrexate—urinary bladder cancer	0.00387	0.00418	CcSEcCtD
Mafenide—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00387	0.00418	CcSEcCtD
Mafenide—Haemorrhage—Doxorubicin—urinary bladder cancer	0.00385	0.00415	CcSEcCtD
Mafenide—Rash—Fluorouracil—urinary bladder cancer	0.00383	0.00413	CcSEcCtD
Mafenide—Dermatitis—Fluorouracil—urinary bladder cancer	0.00382	0.00413	CcSEcCtD
Mafenide—Pruritus—Etoposide—urinary bladder cancer	0.00373	0.00403	CcSEcCtD
Mafenide—Rash—Cisplatin—urinary bladder cancer	0.00363	0.00392	CcSEcCtD
Mafenide—Dermatitis—Cisplatin—urinary bladder cancer	0.00362	0.00391	CcSEcCtD
Mafenide—Erythema—Epirubicin—urinary bladder cancer	0.00362	0.00391	CcSEcCtD
Mafenide—Diarrhoea—Etoposide—urinary bladder cancer	0.00361	0.00389	CcSEcCtD
Mafenide—Erythema—Doxorubicin—urinary bladder cancer	0.00335	0.00362	CcSEcCtD
Mafenide—Rash—Etoposide—urinary bladder cancer	0.00332	0.00359	CcSEcCtD
Mafenide—Dermatitis—Etoposide—urinary bladder cancer	0.00332	0.00358	CcSEcCtD
Mafenide—Pain—Methotrexate—urinary bladder cancer	0.0027	0.00291	CcSEcCtD
Mafenide—Pain—Epirubicin—urinary bladder cancer	0.00253	0.00273	CcSEcCtD
Mafenide—Urticaria—Methotrexate—urinary bladder cancer	0.00251	0.00271	CcSEcCtD
Mafenide—Urticaria—Epirubicin—urinary bladder cancer	0.00235	0.00253	CcSEcCtD
Mafenide—Pain—Doxorubicin—urinary bladder cancer	0.00234	0.00252	CcSEcCtD
Mafenide—Pruritus—Methotrexate—urinary bladder cancer	0.00223	0.00241	CcSEcCtD
Mafenide—Urticaria—Doxorubicin—urinary bladder cancer	0.00217	0.00234	CcSEcCtD
Mafenide—Diarrhoea—Methotrexate—urinary bladder cancer	0.00216	0.00233	CcSEcCtD
Mafenide—Pruritus—Epirubicin—urinary bladder cancer	0.00209	0.00226	CcSEcCtD
Mafenide—Diarrhoea—Epirubicin—urinary bladder cancer	0.00202	0.00218	CcSEcCtD
Mafenide—Rash—Methotrexate—urinary bladder cancer	0.00199	0.00215	CcSEcCtD
Mafenide—Dermatitis—Methotrexate—urinary bladder cancer	0.00199	0.00215	CcSEcCtD
Mafenide—Pruritus—Doxorubicin—urinary bladder cancer	0.00193	0.00209	CcSEcCtD
Mafenide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00187	0.00202	CcSEcCtD
Mafenide—Rash—Epirubicin—urinary bladder cancer	0.00186	0.00201	CcSEcCtD
Mafenide—Dermatitis—Epirubicin—urinary bladder cancer	0.00186	0.00201	CcSEcCtD
Mafenide—Rash—Doxorubicin—urinary bladder cancer	0.00172	0.00186	CcSEcCtD
Mafenide—Dermatitis—Doxorubicin—urinary bladder cancer	0.00172	0.00186	CcSEcCtD
